Status:
RECRUITING
Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors
Lead Sponsor:
Roswell Park Cancer Institute
Conditions:
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial evaluates whether a supervised community-based exercise and nutrition program is usable and effective for improving cancer survivors' confidence for maintaining their physical acti...
Detailed Description
PRIMARY OBJECTIVE: I. To assess the feasibility and acceptability of a 12-week supervised community-based exercise/nutrition training and education program for cancer survivors. SECONDARY OBJECTIVE:...
Eligibility Criteria
Inclusion
- Age ≥ 18 years.
- Have had a previous cancer diagnosis and completed all therapy OR are a caregiver for a patient who has had a previous cancer diagnosis.
- Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related interventions.
Exclusion
- Have uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia including atrial fibrillation (AFIB), multiple myeloma, or psychiatric illness/social situations that would limit compliance with study requirements.
- Have orthopedic or neuromuscular disorders or arthritis that preclude participation in exercise.
- Are pregnant or nursing.
- History of a stem cell transplant.
- Currently on steroids.
- Unwilling or unable to follow protocol requirements.
- Any condition which in the investigator's opinion deems the participant an unsuitable candidate to participate in the study.
Key Trial Info
Start Date :
February 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2029
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06565260
Start Date
February 1 2026
End Date
August 30 2029
Last Update
December 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Roswell Park Cancer Institute
Buffalo, New York, United States, 14263